- About Overview
- Honors and Awards
- Facts and Figures
- Support the School
- Contact Us
- Dean’s Office
- Dean’s Office Overview
- Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Org Chart
- Patient Care
Study reveals how to make gasoline from yeast and bacterium
By UCSF School of Pharmacy Editorial Staff / Wed Apr 22, 2009
A chemical precursor molecule of gasoline can be produced from biomass and salt, according to research by UCSF School of Pharmacy's Christopher Voigt, PhD, and UCSF colleagues. In this case, the precursor is methyl halide, and the gasoline derived from it through catalytic conversion is chemically indistinguishable from that produced from petroleum and would not require new vehicle engines, according to Voigt. In addition to gasoline, methyl halides can also be converted to other industrial fuels and chemicals. Voigt's approach to methyl halide production uses cellulose-rich, non-food crop waste or grasses and consequently would not displace food-producing crops.
The results of this research were published online April 20, 2009 by the Journal of the American Chemical Society and have subsequently attracted international media attention. Voigt, who is a professor in the Department of Pharmaceutical Chemistry, is the principal investigator of the study. Team members are postdoctoral fellow Travis Bayer, PhD; PhD graduate students Daniel Widmaier, Karsten Temme, and Ethan Mirsky; and pharmaceutical chemistry faculty member Daniel Santi, PhD.
Using tools from synthetic biology, the group programmed the DNA of yeast to produce methyl halides from biomass and salt. In doing so, they created an artificial symbiotic relationship between a bacterium and yeast. The bacterium, which was originally isolated from a French garbage dump, can eat non-food agricultural waste and convert it to a form that the yeast can then turn into methyl halides.
Methyl halides have been extensively explored as an intermediate for the conversion of natural gas to gasoline, but they have been completely overlooked as potential building blocks from biomass, says Voigt. This is the first study to combine a yeast and a bacterium in fermentation to produce a fuel precursor from agricultural waste.
"If this process were scaled up, we could potentially supplement or replace our dependence on non-renewable petroleum-based fuels and do so in an environmentally responsible way," explains Voigt who estimates that a pilot plant could be ready for construction in about three years, pending the availability of funding.
The study behind Voigt's current Journal of the American Chemical Society paper was funded primarily through private support received by Voigt from the David & Lucile Packard Foundation through a 2006 Packard Fellowship for Science and Engineering. These awards are intended to allow the nation's most promising professors to pursue science and engineering research early in their careers with few funding restrictions and limited paperwork requirements.
Voigt is a faculty affiliate of the University of California's California Institute for Quantitative Biosciences, which aims to integrate and expand the understanding of biological systems by using the quantitative tools and techniques of chemistry, engineering, math, and physics.
- Gold in Garbage: Californian Researchers Develop Biomass-based Methyl Halides, ICIS.com, June 22, 2009
- Bacteria could help solve the energy crisis, KGO (ABC 7), June 18, 2009
- Bio Hacking the Way to Make Bio Gasoline, New Energy and Fuel, April 24, 2009
- Yeast and Bacterium Turned into Gasoline Factory, New Scientist, April 20, 2009
- Californians Engineer Microbes to Produce Methyl Halides, Biomass Magazine, April 21, 2009
- Lab Finds New Method to Turn Biomass into Gasoline, Reuters, April 21, 2009
- Methyl Halides Made From Raw Biomass, Chemical & Engineering News, May 18, 2009
- Synthetic Bio Could Cure Energy Woes, Genetic Engineering and Biotechnology News, December 1, 2009
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.